Outcomes from Gleason 7, intermediate risk, localized prostate cancer treated with Iodine-125 monotherapy over 10
years
To access this article, please choose from the options below
PII: S0167-8140(10)00155-6
doi:10.1016/j.radonc.2010.03.004
© 2010 Elsevier Ireland Ltd. All rights reserved.
